Bloomin' Brands reported its strongest quarterly beat in recent memory this morning, yet the stock has barely budged — a combination of a freshly minted JP Morgan downgrade and a short position that remains elevated even after a sharp month-long unwind.
Q1 2026 earnings dropped before the open on May 6. Adjusted EPS of $0.67 cleared the $0.57 consensus by a wide margin. Revenue of $1.059B topped estimates of $1.040B. Q2 adjusted EPS guidance of $0.27–$0.32 also came in above the $0.22 consensus. The company affirmed full-year adjusted EPS guidance of $0.75–$0.90, bracketing the $0.84 Street estimate. Revenue was $1.059B compared with $1.050B a year ago, with net income climbing to $55.65M from $42.15M. By most measures it was a clean print — yet the stock added just 2.3% on the day and remains down 4.5% for the week.
That muted reaction is largely explained by the analyst backdrop. JP Morgan's John Ivankoe downgraded BLMN to Underweight with a $6.00 target on April 24 — less than two weeks before today's print — representing genuine downside from the current $5.76 price. It was a meaningful directional call from a bellwether firm, and it shifted the tone heading into results. The broader analyst community is split but leaning cautious: Citigroup holds a Neutral with a $7.00 target, Goldman Sachs maintains a Sell with a $6.50 target (flagged prior to today), and Freedom Capital initiated at Buy with a $10.00 target. The mean price target of around $7.52 implies roughly 30% upside from here — but with JP Morgan and Goldman both below the current price, the distribution of views is far from uniform. The EV/EBITDA multiple of 8.2x has crept modestly higher over the past month, and the price-to-book of 0.99x underscores just how cheaply the market still values the restaurant operator's asset base.
Short positioning has been one of the more interesting sub-plots over the past six weeks. Shorts were carrying more than 11% of the free float through late March and into early April — a notably heavy load for a casual dining name. That position unwound sharply: the SI % of free float dropped from 11.1% on April 9 to around 9.3% today, a decline of roughly 17% in raw shares over the past month. The move appears linked to the mid-April tariff-related market volatility, after which a subset of bears covered. Importantly, despite the unwind, short interest is still elevated. Nine-plus percent of the free float remains short, and borrow conditions stay comfortably loose — availability is broad, cost to borrow has slid to 0.48% from above 0.59% a month ago, and availability of borrow relative to the short position is ample. There is no squeeze dynamic here. The ORTEX short score of 47.7 sits near the middle of its range, consistent with a moderately-shorted name where the bear thesis is alive but not crowded.
Options positioning adds little urgency. The put/call ratio of 0.51 is slightly below its 20-day average of 0.52, with a z-score of -0.47 — essentially flat, close to the least defensive reading of the year relative to that average. The 52-week PCR range spans 0.30 to 1.02, so current readings are well within normal territory. That indifference in the options market is somewhat at odds with the JP Morgan downgrade — it suggests options traders are not yet positioning for meaningful downside, even as the formal analyst stance has turned more negative.
On the ownership side, Starboard Value remains the largest disclosed holder at 9.4% with no change reported through year-end 2025 — a noteworthy presence given the activist firm's typical appetite for operational change. Mirae Asset added a very large block in Q1 2026, filing a position of over 2.7M shares, nearly all of it new. BlackRock and Vanguard both added modestly in the same period. The index removal — BLMN was dropped from the S&P 600 and S&P Composite 1500 in late March — has already passed as a forced-selling event, reducing overhang.
The key question now is whether today's earnings beat is enough to move the Street off its cautious footing. With JP Morgan formally negative and Goldman at Sell, the next catalyst is likely analyst reaction to the Q1 print and any revision to Q2 or full-year guidance — particularly around the Outback comparable sales trajectory, which remains the bear case's central data point.
See the live data behind this article on ORTEX.
Open BLMN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
